3TCP
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-12-10 |
Detector | MARMOSAIC 300 mm CCD |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 51.158, 91.142, 68.356 |
Unit cell angles | 90.00, 100.35, 90.00 |
Refinement procedure
Resolution | 29.020 - 2.690 |
R-factor | 0.228 |
Rwork | 0.225 |
R-free | 0.29800 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3brb |
RMSD bond length | 0.008 |
RMSD bond angle | 1.147 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0110) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 29.020 | 2.720 |
High resolution limit [Å] | 2.690 | 2.690 |
Rmerge | 0.098 | 0.522 |
Number of reflections | 16603 | |
<I/σ(I)> | 14.7 | 1.5 |
Completeness [%] | 96.3 | 59.3 |
Redundancy | 3.6 | 2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8.5 | 288 | Protein: 32.5 mg/mL in 20 mM Tris pH 8.0, 500mM sodium chloride, 2mM beta-mercaptoethanol; incubated with inhibitor (2.5 mM final concentration) overnight; Mixed 1:1 with crystallization solution (27-33% (v/v) Peg400, 200 mM magnesium chloride, 100 mM Tris pH 8.5), VAPOR DIFFUSION, SITTING DROP, temperature 288K |